Search
for
Sort by
Research 421–450 of 479
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Understanding the Impact of Reperfusion in the Development of a Safe Compression Therapy
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Multi-omics analyses, cell experiments, and network pharmacology tools identified key proteins and candidate drugs for alopecia areata treatment
- Understanding the Association Between Mental Health and Hair Loss
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- Adipose Tissue–Derived Exosomes as a Novel Therapeutic Approach for Refractory Alopecia Areata: A Report of Two Cases
- Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Dandruff lesional scalp skin exhibits epidermal T cell infiltration and a weakened hair follicle immune privilege
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Insights into Alopecia Areata: A Systematic Review of Prevalence, Pathogenesis, and Psychological Consequences
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Targeted immunotherapy for hair regrowth and regeneration